Progenics Pharmaceuticals progenics.com

Progenics Pharmaceuticals is discovering and developing medicines to treat disease, focusing on cancer and related conditions, with a pipeline that includes product candidates in preclinical through late-stage development. Progenics' first commercial product, Relistor (methylnaltrexone bromide) for opioid-induced constipation, is marketed and in further development by Salix Pharmaceuticals for markets worldwide other than Japan, where Ono Pharmaceutical Co. holds an exclusive license for the sub...Show all

Progenics Pharmaceuticals is discovering and developing medicines to treat disease, focusing on cancer and related conditions, with a pipeline that includes product candidates in preclinical through late-stage development. Progenics' first commercial...Show all

See All Exits Recent Exits

Phone: 914-789-2800

Fax:

777 Old Saw Mill Road

Tarrytown, 10591
New York, United States

Progenics Pharmaceuticals - Investments & Acquisitions

Show Real Data Progenics Pharmaceuticals Investments
See all Recent Investments
Date Company Round Amount Co-investors
2013-01-23Molecular Insight PharmaceuticalsAcq - P2P
See all 1 investments